197 related articles for article (PubMed ID: 35234917)
1. HnRNP D activates production of HPV16 E1 and E6 mRNAs by promoting intron retention.
Cui X; Hao C; Gong L; Kajitani N; Schwartz S
Nucleic Acids Res; 2022 Mar; 50(5):2782-2806. PubMed ID: 35234917
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
4. hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs.
Hao C; Zheng Y; Jönsson J; Cui X; Yu H; Wu C; Kajitani N; Schwartz S
Nucleic Acids Res; 2022 Apr; 50(7):3867-3891. PubMed ID: 35357488
[TBL] [Abstract][Full Text] [Related]
5. A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization.
Jönsson J; Wang L; Kajitani N; Schwartz S
Nucleic Acids Res; 2024 Jan; 52(1):316-336. PubMed ID: 37994701
[TBL] [Abstract][Full Text] [Related]
6. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.
Tang S; Tao M; McCoy JP; Zheng ZM
J Virol; 2006 May; 80(9):4249-63. PubMed ID: 16611884
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.
Bodaghi S; Jia R; Zheng ZM
Virology; 2009 Mar; 386(1):32-43. PubMed ID: 19187948
[TBL] [Abstract][Full Text] [Related]
8. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
9. [Effects of hnRNP E1 on expression of early genes E2, E6 of HPV16 and biological function in cervical cancer cells].
Song L; Ding L; Feng MJ; Li XX; Gao W; Qi Z; Liu H; Wang M; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Feb; 42(2):321-326. PubMed ID: 33626623
[No Abstract] [Full Text] [Related]
10. [Effects of hnRNP E1 and both early genes E2 and E6 of HPV16 together with their interactions on cervical carcinogenesis].
Lyu YJ; Ding L; Li QL; Li L; Wang M; Han Y; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Apr; 40(4):466-470. PubMed ID: 31006210
[No Abstract] [Full Text] [Related]
11. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
Cui X; Nilsson K; Kajitani N; Schwartz S
Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
[TBL] [Abstract][Full Text] [Related]
13. hnRNP K induces HPV16 oncogene expression and promotes cervical cancerization.
Lyu Y; Song L; Mao R; Liu C; Feng M; Wu C; Pei R; Ding L; Wang J
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6225-6237. PubMed ID: 36700980
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
[TBL] [Abstract][Full Text] [Related]
15. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
16. A transcriptomic landscape of human papillomavirus 16 E6-regulated gene expression and splicing events.
Xu J; Fang Y; Qin J; Chen X; Liang X; Xie X; Lu W
FEBS Lett; 2016 Dec; 590(24):4594-4605. PubMed ID: 27859058
[TBL] [Abstract][Full Text] [Related]
17. Coordinated action of human papillomavirus type 16 E6 and E7 oncoproteins on competitive endogenous RNA (ceRNA) network members in primary human keratinocytes.
László B; Antal L; Gyöngyösi E; Szalmás A; Póliska S; Veress G; Kónya J
BMC Cancer; 2021 Jun; 21(1):673. PubMed ID: 34098875
[TBL] [Abstract][Full Text] [Related]
18. Intron definition and a branch site adenosine at nt 385 control RNA splicing of HPV16 E6*I and E7 expression.
Ajiro M; Jia R; Zhang L; Liu X; Zheng ZM
PLoS One; 2012; 7(10):e46412. PubMed ID: 23056301
[TBL] [Abstract][Full Text] [Related]
19. 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.
Morel A; Baguet A; Perrard J; Demeret C; Jacquin E; Guenat D; Mougin C; Prétet JL
Oncotarget; 2017 Jul; 8(28):46163-46176. PubMed ID: 28521287
[TBL] [Abstract][Full Text] [Related]
20. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.
Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J
Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
